| BMY Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the BMY market cap history going back to 2/1/2010:
Also see: BMY Shares Outstanding History and BMY YTD Return |
BMY Market Cap History — Bristol-Myers Squibb Capitalization Over Time
As of 4/21/2026 Bristol-Myers Squibb has a market cap of 121.28 billion. Investors often follow the BMY market cap history to compare the size of the company over time.
This page shows BMY market capitalization trends over time, with 65 market cap datapoints presented, dating back to 2/1/2010.
| BMY Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BMY Historical Market Cap: +6.79% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BMY Stock Price Chart |
| About Bristol Myers Squibb Co. |
| Bristol-Myers Squibb Co. is a biopharmaceutical company engaged in the discovery, development and delivering advanced medicines that help patients prevail over serious diseases. It offers products for various therapeutic classes, which includes oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric antigen receptor (CAR-T) cell therapies. Small molecule drugs are typically administered orally in the form of a tablet or capsule, although other drug delivery mechanisms are used as well. We show 65 historical shares outstanding datapoints in our BMY shares outstanding history coverage, used to compute BMY market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing BMY market cap history over the course of time is important for investors interested in comparing BMY's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of BMY versus a peer is one thing; comparing BMY market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like BMY can fluctuate over the course of history. With this page we aim to empower investors researching BMY by allowing them to research the BMY market cap history. |
| BMY Current Stock Quote |
Quotes delayed 20 minutes  Free BMY Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| BMY Share Performance |
| Market Cap Peers |
| Bristol-Myers Squibb (BMY) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
BNBX Market Cap History BNGO Market Cap History BNTC Market Cap History BOLD Market Cap History BOLT Market Cap History BPMC Market Cap History BPTH Market Cap History BRKR Market Cap History BRTX Market Cap History BSGM Market Cap History More Healthcare companies » |
BMY Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
